Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Yxoss CBR®

K-Number: K192747 · 2020-06-17

ApplicantReoss GmbH
Decision Date2020-06-17
Product CodeJEY
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

Yxoss CBR® is the device name listed in this FDA 510(k) record. The listed applicant is Reoss GmbH. It received FDA 510(k) clearance on 2020-06-17 under 510(k) number K192747. The device is classified under product code JEY. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Yxoss CBR®?

Yxoss CBR® is a medical device that received FDA 510(k) clearance on 2020-06-17. The listed applicant is Reoss GmbH. The 510(k) number is K192747.

When did Yxoss CBR® receive FDA 510(k) clearance?

Yxoss CBR® received FDA 510(k) clearance on 2020-06-17, under 510(k) number K192747.

Who is the listed applicant for Yxoss CBR®?

The FDA 510(k) record lists Reoss GmbH as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Yxoss CBR®?

The FDA product code for Yxoss CBR® is JEY.

Related Devices (Code: JEY)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.